Rapid response to anakinra in patients with refractory Adult Onset Still's Disease (AOSD).

被引:0
|
作者
Fitzgerald, AA
LeClercq, SA
Yan, A
Homik, JE
Dinarello, CA
机构
[1] Univ Calgary, Calgary, AB T2N 1N4, Canada
[2] Royal ALexandra Hosp, Edmonton, AB, Canada
[3] Univ Colorado, Denver, CO 80202 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S176 / S176
页数:1
相关论文
共 50 条
  • [21] TOCILIZUMAB COMPARED WITH ANAKINRA IN REFRACTORY ADULT-ONSET STILL'S DISEASE. MULTICENTER STUDY OF 75 PATIENTS
    Palmou, N.
    Calvo-Rio, V.
    Blanco, R.
    Hernandez, J. L.
    Ortiz-Sanjuan, F.
    Olive, A.
    Riveros, A.
    Castaneda, S.
    Narvaez, F. J.
    Velloso-Feijoo, M. L.
    Hernandez, M. V.
    Sifuentes Giraldo, W. A.
    Maiz Alonso, O.
    Rubio Romero, E.
    Mata, C.
    Gallego Flores, A.
    del Blanco-Barnusell, J.
    Gomez-Arango, C.
    Ordonez, M. D. C.
    Caracuel, M. A.
    Velloso Feijoo, M. L.
    Jimenez-Moleon, I.
    Bernal, J. A.
    Gonzalez-Gay, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 850 - 850
  • [22] Myocardial dysfunction in a patient with adult-onset Still's disease (AOSD)
    Nishimagi, E
    Hirata, S
    Kawaguchi, Y
    Okamoto, H
    Hara, M
    Kamatani, N
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (04) : 506 - 507
  • [23] Diagnostic value of serum ferritin in adult onset still's disease (AOSD)
    Lian, F
    Yang, X
    Liang, L
    Ye, Y
    Zhan, Z
    Xu, H
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 554 - 554
  • [24] Anakinra Treatment in Refractory Cases of Adult-Onset Still Disease: Case Series
    Ugurlu, Serdal
    Yurttas, Berna
    Guzelant, Gul
    Ergezen, Bilgesu
    Ozdogan, Huri
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [25] ANAKINRA TREATMENT IN REFRACTORY CASES OF ADULT-ONSET STILL DISEASE: CASE SERIES
    Ugurlu, S.
    Yurttas, B.
    Guzelant, G.
    Ergezen, B.
    Ozdogan, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1164 - 1164
  • [26] Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease
    Ahmed, Osman
    Brahmania, Mayur
    Alsahafi, Majid
    Alkhowaiter, Saad
    Erb, Sig
    ACG CASE REPORTS JOURNAL, 2015, 2 (03): : 173 - 174
  • [27] EFFICACY OF ANAKINRA IN REFRACTORY ADULT-ONSET STILL'S DISEASE: MULTICENTER OPEN-LABEL STUDY OF 34 PATIENTS
    Ortiz Sanjuan, F. M.
    Blanco, R.
    Olive, A.
    Riveros, A.
    Castaneda, S.
    Velloso-Feijoo, M. L.
    Narvaez, F. J.
    Jimenez-Moleon, I.
    Ordonez, C.
    Bernal, J. A.
    Sifuentes-Giraldo, W. A.
    Gomez-Arango, C.
    Galindez-Agirregoikoa, E.
    Ortiz-Santamaria, V.
    del Blanco-Barnusell, J.
    De Dios, J. R.
    Moreno, M.
    Fiter, J.
    Loricera, J.
    Calvo-Rio, V.
    Pina, T.
    Gonzalez-Gay, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 316 - 317
  • [28] Cytokine Storm: Adult-Onset Still's Disease (AOSD), Myocarditis, and Hemophagocytosis
    Palkar, Atul
    Sahni, Sonu
    Oks, Margarita
    Talwar, Arunabh
    Gottesman, Eric
    CHEST, 2015, 148 (04)
  • [29] Rapidly Progressing Pulmonary Fibrosis From Adult Onset Still's Disease (AOSD)
    Hoang, Quynh
    Patino, Rene
    Wei, Kenneth
    CHEST, 2015, 148 (04)
  • [30] Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease
    Campochiaro, C.
    Farina, N.
    Tomelleri, A.
    De Luca, G.
    Cavalli, G.
    Dagna, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1598 - 1599